Immatics (IMTX) has released an update. Immatics has reported promising updated Phase 1b clinical data for its ACTengine ...
In the Phase 1b dose expansion part of the study, heavily pretreated patients with metastatic melanoma were treated with IMA203. Data from the study showed a significant positive shift in median ...
Immatics has vaulted into phase 3 on the strength of early-stage data. The biotech is gearing up to start a pivotal trial of ...
The City of Jackson began Phase 1A of the "Street Resurfacing Project" in October 2023. A year later, only 22 of 31 streets ...
Poseida’s partnerships with Roche and Astellas aim to advance CAR-T therapies. See PSTX stock details and the impact of ...
(RTTNews) - Viking Therapeutics, Inc. (VKTX), Wednesday announced positive data from Phase 1b study of VK0214 in patients with X-linked adrenoleukodystrophy (X-ALD). X-ALD is a rare and often fatal ...
Data showed a 91% ORR with P-BCMA-ALLO1 in an optimized lymphodepletion arm, including a 100% ORR in BCMA-naïve patients, and ...
Company announces updated Phase 1b clinical data on ACTengine® IMA203 targeting PRAME in 28 heavily pretreated metastatic melanoma patients with substantially enhanced maturity compared to the last ...
The next phase of a Durango-La Plata County Airport terminal expansion is ready for takeoff after Wednesday’s groundbreaking ...
BerGenBio announces safety data from phase 1b portion of BGBC016 study in first-line NSCLC: Bergen, Norway Tuesday, October 8, 2024, 15:00 Hrs [IST] BerGenBio ASA, a clinical-stag ...
ImmuneSensor begins patient dosing in phase 1 trial of lead cGAS inhibitor drug candidate, IMSB301 to treat inflammatory and autoimmune diseases: Dallas, Texas Thursday, October 1 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback